These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8846746)

  • 1. The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
    Gottschlich R; Barber A; Bartoszyk GD; Seyfried CA
    Drugs Exp Clin Res; 1995; 21(5):171-4. PubMed ID: 8846746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
    Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
    Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
    Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
    J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W; Walker JS
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753.
    Gottschlich R; Krug M; Barber A; Devant RM
    Chirality; 1994; 6(8):685-9. PubMed ID: 7857777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
    Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
    Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kappa-opioid receptor agonist asimadoline inhibits epithelial transport in mouse trachea and colon.
    Schreiber R; Bartoszyk GD; Kunzelmann K
    Eur J Pharmacol; 2004 Oct; 503(1-3):185-90. PubMed ID: 15496313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylacetamides as peripherally restricted kappa opioid receptor agonists.
    Kumar V; Marella MA; Cortes-Burgos L; Chang AC; Cassel JA; Daubert JD; DeHaven RN; DeHaven-Hudkins DL; Gottshall SL; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2567-70. PubMed ID: 11086731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
    Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
    Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
    Zhou L; Zhang Q; Stein C; Schäfer M
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
    DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
    J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.
    Caram-Salas NL; Reyes-García G; Bartoszyk GD; Araiza-Saldaña CI; Ambriz-Tututi M; Rocha-González HI; Arreola-Espino R; Cruz SL; Granados-Soto V
    Eur J Pharmacol; 2007 Nov; 573(1-3):75-83. PubMed ID: 17643411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic properties.
    Valenzano KJ; Miller W; Chen Z; Shan S; Crumley G; Victory SF; Davies E; Huang JC; Allie N; Nolan SJ; Rotshteyn Y; Kyle DJ; Broglé K
    J Pharmacol Exp Ther; 2004 Aug; 310(2):783-92. PubMed ID: 15054115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat.
    Skuza G; Kolasiewicz W; Dziedzicka-Wasylewska M; Margas W
    Pol J Pharmacol; 1998; 50(6):399-406. PubMed ID: 10385922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonists.
    Chu GH; Gu M; Cassel JA; Belanger S; Stabley GJ; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
    Bioorg Med Chem Lett; 2006 Feb; 16(3):645-8. PubMed ID: 16263278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.